Aberdeen Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $829K | Hold |
7,720
| – | – | 0.55% | 56 |
|
|
2025
Q1 | $779K | Hold |
7,720
| – | – | 0.54% | 52 |
|
|
2024
Q4 | $690K | Sell |
7,720
-250
| -3% | -$22.3K | 0.47% | 62 |
|
|
2024
Q3 | $668K | Hold |
7,970
| – | – | 0.44% | 68 |
|
|
2024
Q2 | $614K | Hold |
7,970
| – | – | 0.42% | 69 |
|
|
2024
Q1 | $546K | Hold |
7,970
| – | – | 0.32% | 84 |
|
|
2023
Q4 | $461K | Hold |
7,970
| – | – | 0.33% | 88 |
|
|
2023
Q3 | $421K | Hold |
7,970
| – | – | 0.32% | 90 |
|
|
2023
Q2 | $431K | Hold |
7,970
| – | – | 0.31% | 95 |
|
|
2023
Q1 | $399K | Hold |
7,970
| – | – | 0.3% | 96 |
|
|
2022
Q4 | $369K | Hold |
7,970
| – | – | 0.28% | 103 |
|
|
2022
Q3 | $309K | Hold |
7,970
| – | – | 0.27% | 102 |
|
|
2022
Q2 | $297K | Hold |
7,970
| – | – | 0.24% | 111 |
|
|
2022
Q1 | $353K | Hold |
7,970
| – | – | 0.24% | 109 |
|
|
2021
Q4 | $339K | Hold |
7,970
| – | – | 0.22% | 108 |
|
|
2021
Q3 | $346K | Hold |
7,970
| – | – | 0.33% | 99 |
|
|
2021
Q2 | $341K | Hold |
7,970
| – | – | 0.31% | 101 |
|
|
2021
Q1 | $308K | Sell |
7,970
-451
| -5% | -$17.4K | 0.24% | 116 |
|
|
2020
Q4 | $303K | Buy |
8,421
+451
| +6% | +$16.2K | 0.23% | 110 |
|
|
2020
Q3 | $305K | Sell |
7,970
-637
| -7% | -$24.4K | 0.29% | 99 |
|
|
2020
Q2 | $302K | Buy |
8,607
+230
| +3% | +$8.07K | 0.32% | 95 |
|
|
2020
Q1 | $273K | Hold |
8,377
| – | – | 0.33% | 92 |
|
|
2019
Q4 | $379K | Buy |
+8,377
| New | +$379K | 0.28% | 91 |
|